SemaThera Inc
Biotechnology Research
Ca
6 employees
- Employees
- 6
- Contacts
- 3
- Emails
- 3
- Phones
- 1
SemaThera Inc Overview
- Headquarters
- Ca
- Website
- semathera.com
- Industry
- Biotechnology Research
- Employees
- 6
- Founded
- 2016
- Funding
- 2.6M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About SemaThera Inc
SemaThera is a spin-off company from AmorChem Fund 1, which focuses on a novel target, semaphorin 3A (SEMA3A). The Company is currently developing bispecific SEMA3A / VEGF inhibitors (traps) to prevent vascular leakage and damper the inflammation in diabetic macular edema (DME). The technology targets the 30% DME patients who are poor responders to current anti-VEGF therapies.
SemaThera Inc Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 1
- 25.0% coverage
SemaThera Inc Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Garth C. |
View
|
||
| Véronique Bougie | Executive with a Passion for Innovation | Montreal, Quebec, Canada |
Email
Phone
|
| Mike (Przemyslaw) Sapieha | Endowed Chair of Ophthalmology Research | United States |
Email
|
| Elizabeth Douville, Phd, Icd.d | Life Sciences Executive | Montreal, Quebec, Canada |
Email
|
Employees by Management Level
Individual contributor
5 profiles
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| General | 2 | 2 | 1 |
SemaThera Inc Tech Stack
Data / AI
2 profiles
Compare Similar Companies to SemaThera Inc
Theratechnologies Inc.
Biotechnology Research
Epitopea
Biotechnology
UNITY Biotechnology
Biotechnology Research
Thryv Therapeutics Inc.
Biotechnology Research
Cyclenium Pharma Inc.
Biotechnology Research
Anasens
Nanotechnology Research
Laurent Pharmaceuticals
Biotechnology Research
Synucure Therapeutics
Biotechnology Research
Cordex Biologics
Biotechnology Research
MyX Therapeutics
Pharmaceutical Manufacturing